Skip to Content

Notice

Expansion of HIV/AIDS, STD and TB Laboratory Activities at the National Institute for Communicable Diseases (NICD) in the Republic of South Africa Notice of Intent To Fund Single Eligibility Award

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

A. Purpose

The Centers for Disease Control and Prevention (CDC) announces the intent to award fiscal year (FY) 2003 funds for a cooperative agreement program for the expansion of HIV/AIDS, STD and TB laboratory activities in the Republic of South Africa. The Catalog of Federal Domestic Assistance Number for this program is 93.941.

B. Eligible Applicant

Assistance will be provided only to the National Institute of Communicable Diseases (NICD) in South Africa. NICD has the legal authority, expertise, and capacity to perform the key public health role of monitoring communicable diseases such as AIDS, sexually transmitted diseases, and tuberculosis in South Africa.

C. Funding

Approximately $500,000 is available in FY 2003 to fund this award. It is expected that the award will begin on or about March 1, 2003, and will be made for a 12-month budget period within a project period of up to five years. Funding estimates may change.

D. Where To Obtain Additional Information

For general comments or questions about this announcement, contact: Technical Information Management, Start Printed Page 12701CDC Procurement and Grants Office, 2920 Brandywine Road, Atlanta, GA 30341-4146. Telephone: 770-488-2700.

For technical questions about this program, contact: David M. Allen, M.D., M.P.H., CDC Global AIDS Program, U.S. Embassy, P.O. Box 9536, Pretoria, South Africa 0001, Telephone: 27 12 346 0170, E-mail: allend@sacdc.co.za.

Start Signature

Dated: March 11, 2003.

Sandra R. Manning,

Director, Procurement and Grants Office, Centers for Disease Control and Prevention.

End Signature End Preamble

[FR Doc. 03-6264 Filed 3-14-03; 8:45 am]

BILLING CODE 4163-18-P